Latest & greatest articles for autism

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on autism or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on autism and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Autism

Autism is a neurodevelopmental disorder (a type of mental disorder) characterised by difficult social interaction, impaired communication (both verbal and non-verbal), and restricted and repetitive behaviours. It forms part of the broader autism spectrum disorder (ASD), a range of similar conditions, including Asperger syndrome.

Autism is a condition that begins from early childhood and is often suspected and diagnosed by ages 1-3. It is a lifelong disability that affects how people interact with others.

Autism causes and treatment

There have been many misconceptions as to what causes autism in the past such as the MMR vaccine and diet. Extensive research and clinical trials have concluded that none of these factors cause autism or ASD. However, the real cause is little understood but research is starting to unpick potential factors such as genetics, pollution and other environmental factors. A current favoured idea is that genes inherited from a child’s parents can make them more vulnerable to developing autism, some researchers suggest that the disorder will only develop when triggered by environmental factors.

The exact cause of autism spectrum disorder is unknown, however research into the disorder suggest that it is caused by several genetic and environmental factors. Genes inherited from a child’s parents can make them more vulnerable to developing autism, some researchers suggest that the disorder will only develop when triggered by environmental factors. Read more in clinical papers on autism.

Autism can be managed with a combination of prescribed medicines and behavioural treatment, depending on the severity of the disorder. Read about clinical trials and medical advancements for the treatment of autism on Trip.

Hot topics in Trip

Users of Trip frequently look at topics around adolescents, therapies, behaviour and screening. They also explore such topics as omega-3 fatty acids, SSRIs and aripiprazole. All these topics, and more, can be easily searched for within Trip.

Top results for autism

261. Intensive intervention programs for children with autism

Intensive intervention programs for children with autism Intensive intervention programs for children with autism Intensive intervention programs for children with autism Ludwig S, Harstall C Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Ludwig S, Harstall C. Intensive intervention programs for children with autism. Edmonton: Alberta (...) Heritage Foundation for Medical Research (AHFMR). HTA 8: Series B. 2001 Authors' objectives

This report aims to review the published research on the effectiveness of intensive behavioural intervention (IBI) programs for children with an autism spectrum disorder (ASD).

Authors' conclusions The three critical reviews evaluated a number of comprehensive treatment programs for young children with ASD. These included programs ranging from strict operant discrimination learning (Lovaas therapy

Health Technology Assessment (HTA) Database.2001

262. Autism and Lovaas treatment: a systematic review of effectiveness evidence

Autism and Lovaas treatment: a systematic review of effectiveness evidence Autism and Lovaas treatment: a systematic review of effectiveness evidence Autism and Lovaas treatment: a systematic review of effectiveness evidence Bassett K, Green C J, Kazanjian A Record Status This is a bibliographic record of a published health technology assessment. The agency responsible for the publication has subsequently been disbanded. No evaluation of the quality of this assessment has been made for the HTA (...) database. Citation Bassett K, Green C J, Kazanjian A. Autism and Lovaas treatment: a systematic review of effectiveness evidence. Vancouver: B. C. Office of Health Technology Assessment, Centre for Health Services and Policy Research, University of British Columbia (BCOHTA) 2000: 57 Authors' objectives The aim of this report is to examine whether early, intensive behavioural therapy for children with autism results in normal functioning, or essentially a cure. Authors' conclusions The report concludes

Health Technology Assessment (HTA) Database.2000

264. Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder.

Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder. 10588965 1999 12 10 1999 12 10 2007 11 14 0028-4793 341 24 1999 Dec 09 The New England journal of medicine N. Engl. J. Med. Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder. 1801-6 Secretin is a peptide hormone that stimulates pancreatic secretion. After recent publicity about a child with autism (...) whose condition markedly improved after a single dose of secretin, thousands of children with autistic disorders may have received secretin injections. We conducted a double-blind, placebo-controlled trial of a single intravenous dose of synthetic human secretin in 60 children (age, 3 to 14 years) with autism or pervasive developmental disorder. The children were randomly assigned to treatment with an intravenous infusion of synthetic human secretin (0.4 microg per kilogram of body weight) or saline

NEJM1999

265. Auditory integration training in autism

Auditory integration training in autism Auditory integration training in autism Auditory integration training in autism Best L, Milne R Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Best L, Milne R. Auditory integration training in autism. Southampton: Wessex Institute for Health Research and Development (WIHRD) 1997 Authors' objectives (...) Auditory integration training (AIT) is a therapeutic listening procedure which is reported to alleviate or improve behaviour, attention, and communication deficits associated with various developmental disorders including autism and pervasive developmental disorders. The authors examine whether it is in fact helpful to people with autism. Authors' conclusions In view of the way that trials have produced conflicting results, and it remains uncertain whether AIT is any more beneficial than a placebo

Health Technology Assessment (HTA) Database.1997

266. Efficacy of vitamin B6 and magnesium in the treatment of autism: a methodology review and summary of outcomes

Efficacy of vitamin B6 and magnesium in the treatment of autism: a methodology review and summary of outcomes Efficacy of vitamin B6 and magnesium in the treatment of autism: a methodology review and summary of outcomes Efficacy of vitamin B6 and magnesium in the treatment of autism: a methodology review and summary of outcomes Pfeiffer S I, Norton J, Nelson L, Shott S Authors' objectives To assess the effectiveness of vitamin B6 and magnesium in the treatment of autism, and to review (...) the methodology of studies in this area. Searching MEDLARS, PsycINFO and Mental Health Abstracts were searched, and the references of all studies published from 1975 were cross-checked. Study selection Study designs of evaluations included in the review Randomised controlled trials (RCTs), non-randomised controlled trials and uncontrolled studies were included. Specific interventions included in the review Vitamin B6 with magnesium. Participants included in the review Persons with autism were included

DARE.1995